MedPath

Tropisetron versus metoclopramide for nausea and vomiting in the emergency department: a randomised, double blinded, clinical trial

Phase 3
Completed
Conditions
nausea and vomiting
Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Registration Number
ACTRN12609000733279
Lead Sponsor
Austin Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria

Patients who have presented to the emergency department for treatment; age 18 years or more; nausea and/or vomiting that requires drug treatment as determined by the treating physician

Exclusion Criteria

Refusal to participate; Migraine (metoclopramide sedation confers an advantage); Inability to co-operate or consent due to debility, significant illness, language barriers, altered consciousness (as determined by the emergency department or study staff); Known allergy or hypersensitivity to tropisetron or metoclopramide; Intoxication (alcohol, substance abuse); Pregnancy; Previous administration of antiemetic within 24 hours

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ausea score (0-100) on a visual analogue scale[0, 30, 60, 90, 120, 180 and 240 minutes after drug injection];Incidence of vomiting[0, 30, 60, 90, 120, 180 and 240 minutes after drug injection]
Secondary Outcome Measures
NameTimeMethod
requirement for rescue medication (additional drugs to control nausea and/or vomiting) as determined by the treating medical staff (not by nausea score)[0, 30, 60, 90, 120, 180 and 240 minutes after drug injection];Side effects including drowsiness (measured using a 5 point sedation scale), dystonic reactions (determined clinically by the treating the clinicians) and akathisia (measured using the Prince Henry Hospital Akathisia Rating Scale.[0, 30, 60, 90, 120, 180 and 240 minutes after drug injection]
© Copyright 2025. All Rights Reserved by MedPath